A man with type 1 diabetes produces his own insulin after receiving genetically-modified donor islet cells, without the need ...
Brian Tait, chief scientific officer, Haplomic Technologies Pty Ltd, explores the clinical benefits of haplotyping in ...
Researchers have harnessed the power of artificial intelligence to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens.
The causal biomarkers for metabolic dysfunction-associated steatotic liver disease (MASLD) and their clinical value remain unclear. In this study, we ...
News-Medical.Net on MSN
Study identifies key molecular and clinical biomarkers for MASLD
Background and aims The causal biomarkers for metabolic dysfunction-associated steatotic liver disease (MASLD) and their clinical value remain unclear. In this study, we aimed to identify biomarkers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback